Oncotype DX breast
Ended Awarded
- Contract number
- HT001417F0329
- Awardee
-
Genomic Health, Inc. UEI RHN3L7SBF7J6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $44,764
Award facts
- Contract value 100% obligated
- $44,763.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Belvoir, VA 22060, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HT001417F0329?
HT001417F0329 was awarded to Genomic Health, Inc. by Defense Health Agency (Department of Defense) on September 22, 2017.
How much is contract HT001417F0329 worth?
The government has obligated $44,764 on HT001417F0329.
Is contract HT001417F0329 an order under another contract?
Yes. HT001417F0329 is a BPA call under HT001416A0144, a blanket purchase agreement.
Was contract HT001417F0329 competed?
The extent of competition for HT001417F0329 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award